Rush University Medical Center

Sorting 1 by

Accepting patients

VICD

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients (VICD)
Learn more
  • Monoclonal Antibody
  • CD38
  • Phase 2